For the first time, research conducted in China has employed the CRISPR gene-editing technique to treat patients with cancer. Should the trial end with no significant side-effects, the method could become widely used.
For the first time, research conducted in China has employed the CRISPR gene-editing technique to treat patients with cancer. Should the trial end with no significant side-effects, the method could become widely used.